base
bioinformat
analysi
middl
east
respiratori
syndrom
coronavviru
merscov
protein
synthes
panel
peptid
coupl
keyhol
limpet
haemocyanin
use
rais
antibodi
rabbit
addit
recombin
receptorbind
domain
rbd
use
rais
polyclon
antibodi
mice
antibodi
rais
speptid
immunis
specif
sensit
protein
express
transfect
cell
indirect
immunofluoresc
assay
western
blot
rbd
effici
elicit
neutral
antibodi
merscov
block
viral
entri
bind
step
furthermor
found
peptid
correspond
aminoacid
residu
protein
elicit
robust
neutral
activ
block
viral
entri
postbind
membran
fusion
step
conclud
aminoacid
residu
protein
carri
neutral
epitop
may
use
develop
vaccin
antivir
agent
merscov
iddl
east
respiratori
syndrom
coronavviru
merscov
novel
b
coronaviru
recent
identifi
caus
agent
sever
acut
respiratori
ill
human
middl
east
find
rais
seriou
concern
possibl
pandem
infect
similar
caus
sever
acut
respiratori
syndromecoronaviru
sarscov
juli
confirm
case
infect
merscov
affect
peopl
die
wwwwhoorg
case
link
mani
region
asia
africa
europ
america
accord
recent
data
peopl
mild
respiratori
ill
may
infect
merscov
case
infect
peopl
respiratori
symptom
patient
chronic
diseas
compromis
immun
system
higher
risk
becom
infect
andor
develop
complic
small
cluster
infect
sever
countri
suggest
persontoperson
transmiss
possibl
close
contact
occur
rapid
identif
effect
therapeut
high
prioriti
current
specif
therapi
vaccin
merscov
result
diseas
sever
high
casefat
rate
merscov
belong
genu
betacoronaviru
famili
coronavirida
sarscov
howev
use
host
cell
receptor
infect
complet
genom
sequenc
indic
new
viru
first
lineag
c
betacoronaviru
speci
known
infect
human
cov
positivestrand
rna
virus
virion
compris
nucleocapsid
n
core
surround
envelop
contain
three
membran
protein
spike
membran
envelop
protein
merscov
type
membran
glycoprotein
known
respons
receptor
bind
membran
fusion
induct
neutralis
antibodi
although
protein
merscov
share
littl
aminoacid
ident
cov
share
common
structur
featur
protein
cov
two
compon
contain
receptorbind
domain
rbd
contain
fusion
peptid
dipeptidyl
peptidas
also
known
identifi
function
receptor
merscov
structur
basi
sreceptor
engag
explor
recent
report
inde
show
presenc
sspecif
neutral
antibodi
merscovinfect
patient
therefor
protein
recogn
primari
target
neutral
antibodi
knowledg
antigen
determin
elicit
neutral
antibodi
could
benefici
develop
protect
vaccin
studi
aim
identifi
neutral
epitop
merscov
protein
may
use
develop
vaccin
therapeut
agent
merscov
infect
although
properli
fold
rbd
could
import
target
neutral
antibodi
demonstr
sarscov
identif
neutral
epitop
could
assist
develop
vaccin
therapeut
merscov
infect
synthes
peptid
differ
region
merscov
protein
base
bioinformat
analysi
use
rais
antibodi
rabbit
recombin
rbd
rrbd
use
rais
polyclon
antibodi
mice
antisera
test
term
abil
bind
protein
deriv
transfect
codonoptim
gene
capac
neutral
merscov
use
vitro
neutral
assay
base
lentivir
pseudotyp
particl
express
fulllength
merscov
protein
confirm
rbd
could
effici
elicit
neutral
antibodi
merscov
essenti
target
vaccin
develop
novel
neutral
epitop
correspond
aminoacid
residu
protein
also
identifi
cell
line
plasmid
cultur
dulbecco
modifi
eagl
medium
life
technolog
supplement
heatinactiv
fetal
bovin
serum
hyclon
penicillin
uml
streptomycin
gml
nonessenti
amino
acid
mm
lglutamin
mm
life
technolog
codonoptim
gene
merscov
deriv
publish
sequenc
genbank
access
number
chemic
synthes
qingk
biotech
engin
servic
co
ltd
express
plasmid
construct
insert
fulllength
gene
pvrc
gift
dr
gari
nabel
vrc
nih
usa
control
cmv
promot
produc
pvrcsi
ncov
encod
proviru
contain
luciferas
hiv
gagpol
encod
spike
glycoprotein
sarscov
pmd
encod
vsvg
glycoprotein
use
gener
pseudovirus
describ
elsewher
aminoacid
sequenc
merscov
protein
download
ncbi
genbank
immunogen
region
contain
potenti
human
bcell
epitop
predict
use
bepipr
abcpr
b
tabl
design
panel
np
peptid
synthes
cystein
residu
ad
c
termin
use
solidphas
method
zhongkeyaguang
co
dissolv
dimethyl
sulfoxid
mgml
addit
peptid
coupl
keyhol
limpet
haemocyanin
klh
nterminu
method
lee
et
al
treat
previou
describ
peptid
analyz
highperform
liquid
chromatographi
mass
spectroscopi
verifi
ident
inform
n
peptid
use
immunogen
list
tabl
rrbd
prepar
base
code
sequenc
merscov
rbd
genbank
access
number
spike
residu
use
bactobac
baculoviru
express
system
life
technolog
purifi
superdex
column
ge
healthcar
previous
describ
purifi
rbd
sarscov
cover
spike
residu
express
cell
gift
dr
yuxian
institut
pathogen
biolog
cam
beij
use
mous
immun
control
tabl
anim
experi
conduct
accord
guidelin
anim
experi
describ
approv
institut
anim
care
use
committe
chines
center
diseas
control
prevent
purifi
rrbd
microgram
per
dose
use
immun
femal
balbc
mice
week
old
rrbd
supplement
complet
freund
adjuv
cfa
sigma
first
immun
incomplet
freund
adjuv
sigma
second
third
immun
mice
immun
thrice
interv
monitor
seroconvers
rrbd
use
enzymelink
immunosorb
assay
elisa
purifi
protein
also
use
immun
mice
follow
protocol
produc
antisera
noncov
irrel
control
test
background
assay
one
milligram
peptid
mix
equal
volum
cfa
use
formul
immun
one
new
zealand
white
rabbit
femal
balbc
week
old
per
group
immun
formul
rais
antibodi
respect
peptid
rabbit
given
tripl
booster
inject
week
initi
immun
incomplet
freund
adjuv
instead
cfa
use
formul
booster
inject
interv
sera
sampl
test
week
last
immun
cell
transfect
individu
sexpress
plasmid
use
lipofectamin
reagent
life
technolog
h
posttransfect
cell
lyse
icecold
ripa
buffer
mm
trishcl
ph
mm
nacl
triton
sd
sodium
deoxychol
supplement
proteas
inhibitor
mixtur
sigma
lysat
kept
ice
min
centrifug
resolv
sdspage
protein
transfer
pvdf
membran
biorad
block
skim
milk
pbst
h
probe
indic
primari
antibodi
appropri
dilut
overnight
next
day
membran
incub
correspond
ird
flour
igg
secondari
antibodi
licor
bioscienc
scan
odyssey
infrar
imag
system
licor
bioscienc
immunofluoresc
assay
ifa
use
detect
ncov
glycoprotein
express
bhk
cell
briefli
bhk
cell
cultur
coverslip
fix
formaldehyd
permeabil
triton
block
bovin
serum
albumin
phosphatebuff
salin
probe
indic
primari
antibodi
h
room
temperatur
wash
cell
incub
respect
alexa
fluor
secondari
antibodi
anoth
h
cell
wash
stain
dapi
detect
nuclei
fluoresc
imag
obtain
analyz
use
lsm
laserscan
confoc
microscop
carl
zeiss
test
immunogen
reactiv
perform
use
rrbd
variou
peptid
antigen
elisa
elisa
procedur
carri
previous
describ
lvcovpp
merscovpp
sarscovpp
produc
transfect
human
embryon
kidney
cell
use
fugen
hd
reagent
roch
combin
pvrcsi
ncov
control
pvrcsi
ncov
replac
pmdg
lvcovpp
harvest
h
posttransfect
viru
titer
present
hiv
antigen
concentr
determin
use
vironostika
antigen
microelisa
system
evalu
neutral
antibodi
rais
variou
peptid
panel
produc
lvcovpp
harbor
luciferas
report
gene
map
entri
step
target
polyclon
antisera
establish
two
lvcovppbas
neutral
assay
distinguish
antibodymedi
interfer
bind
postbind
event
adapt
previous
publish
method
protocol
cleavag
site
heptad
repeat
residu
heptad
repeat
residu
tm
transmembran
domain
residu
rrbd
recombin
rbd
bactobac
system
indic
gray
box
peptid
use
studi
residu
residu
residu
indic
gray
box
serial
dilut
sera
purif
protein
g
column
incub
lvcovpp
h
bind
target
cell
mixtur
ad
cell
infect
h
cell
lyse
luciferas
activ
assay
protocol
ii
lvcovpp
incub
cell
h
antisera
ad
inoculum
assay
antibodi
ad
bind
lvcovpp
target
cell
thu
enabl
us
studi
effect
antibodi
viral
entri
postbind
fusion
step
normal
neutral
calcul
follow
rel
luciferas
unit
pp
mock
serarel
luciferas
unit
pp
immun
serum
given
dilut
rel
luciferas
unit
pp
mock
sera
perform
neutral
assay
use
plate
experi
carri
triplic
signific
differ
experiment
control
group
evalu
oneway
analysi
varianc
use
spss
softwar
releas
spss
inc
differ
consid
signific
p
determin
neutral
epitop
merscov
rrbd
panel
peptid
cover
differ
region
use
antigen
fig
rais
polyclon
antibodi
mice
rabbit
respect
rbd
sarscov
two
peptid
n
merscov
includ
control
antigen
tabl
multipl
booster
inject
perform
attempt
increas
antibodi
titer
specif
immunogen
elicit
high
titer
igg
antibodi
specif
respect
antigen
detect
elisa
fig
mean
endpoint
titer
antirbd
igg
mice
reach
anti
n
peptid
igg
rabbit
reach
last
immun
antisera
peptid
immun
mice
show
high
bind
capac
rbd
merscov
crossreact
observ
antisera
rbd
merscov
rbd
sarscov
vice
versa
addit
merscov
sspecif
antiserum
crossreact
n
peptid
specif
sera
induc
rrbd
sp
peptid
confirm
western
blot
ifa
use
recombin
protein
bhk
cell
transfect
pvrcsi
ncov
fig
antisera
rais
rrbd
peptid
recogn
domin
band
size
kda
pvrcsi
ncov
transfect
lysat
expect
fulllength
monomer
protein
fig
addit
two
major
band
size
kda
detect
antirbd
antisp
sera
like
repres
unglycosyl
form
protein
glycosyl
form
demonstr
merscov
may
cleav
data
also
show
sever
smaller
lowmolecularweight
product
suggest
cleav
sspecif
band
detect
mocktransfect
cell
antiserum
npeptid
immun
rabbit
use
western
blot
specif
band
observ
data
shown
result
indic
antibodi
rais
rrbd
peptid
bound
specif
merscov
investig
whether
polyclon
antibodi
could
specif
bind
nativ
protein
identifi
locat
express
confoc
ifa
use
analyz
express
bhk
cell
transfect
pvrcsi
bind
antisera
protein
cytoplasm
cell
surfac
detect
suggest
polyclon
antibodi
recogn
properli
fold
matur
form
merscov
neutral
activ
merscov
elicit
rrbd
peptid
target
aminoacid
residu
protein
determin
polyclon
antibodi
rrbd
peptid
could
recogn
nativ
form
merscov
protein
test
neutral
activ
assess
neutral
capac
antisera
last
bleed
rabbit
inject
target
residu
protein
target
residu
protein
np
target
residu
n
protein
merscovpp
premix
indic
dilut
antiserum
inocul
cell
luciferas
activ
examin
h
postinfect
fig
antiserum
rabbit
inject
show
neutral
activ
titer
reach
neutral
dilut
recent
report
indic
rbd
could
import
target
neutral
antibodi
confirm
rrbd
elicit
robust
neutral
antibodi
merscov
mice
fig
reach
neutral
dilut
howev
rabbit
antiserum
locat
cterminu
rbd
show
neutral
activ
addit
cd
analysi
peptid
show
linear
data
shown
test
specif
neutral
antibodi
elicit
rrbd
obtain
antiserum
induc
rbd
sarscovimmun
mice
evalu
crossreact
antiserum
two
covpp
merspp
sarspp
result
indic
antiserum
rrbd
merscov
could
effect
neutral
merspp
infect
vitro
neutral
sarspp
infect
fig
contrast
antiserum
sarscov
rbd
effect
neutral
sarspp
infect
vitro
neutral
merspp
infect
result
suggest
neutral
antibodi
induc
rrbd
merscov
specif
crossneutr
sarscov
yang
et
al
map
entri
step
target
neutral
antisera
develop
two
mersppbas
neutral
assay
allow
us
distinguish
bind
postbind
stage
infect
describ
materi
method
inhibitori
antibodi
ad
bind
merspp
target
cell
protocol
antibodi
ad
merspp
bind
target
cell
protocol
ii
expect
antibodi
target
entri
mediat
receptorbind
event
rel
neutral
activ
antirrbd
dilut
ad
bind
protocol
significantli
higher
ad
postbind
protocol
ii
howev
mark
differ
rel
neutral
activ
dilut
shown
protocol
ii
fig
data
suggest
antibodi
inhibit
merspp
entri
postbind
fusion
process
contrast
antirbd
antibodi
develop
effect
vaccin
therapeut
merscov
infect
urgent
need
neutral
antibodi
respons
often
provid
firstlin
adapt
defens
infect
limit
viru
entri
spread
protein
coronavirus
main
determin
tropism
also
major
antigen
target
neutral
antibodi
induct
therefor
use
immunogen
vaccin
develop
far
littl
known
neutral
epitop
capac
merscov
protein
studi
found
rbd
amino
acid
merscov
protein
induc
neutral
antibodi
repres
potenti
target
inhibit
merscov
entri
differ
step
find
import
implic
understand
process
mechan
neutral
also
design
novel
strategi
block
merscov
infect
first
assess
immunogen
reactiv
specif
rbd
panel
peptideklh
conjug
immunogen
mice
rabbit
elisabas
analysi
serum
igg
respons
immunogen
reveal
rbd
immunogen
balbc
mice
peptideklh
conjug
rabbit
robust
immunogenspecif
igg
respons
obtain
sever
immun
western
blot
confoc
ifa
indic
antiserum
might
bind
effici
merscov
protein
express
cytoplasm
membran
size
fulllength
monomer
protein
detect
agreement
expect
publish
data
studi
also
suggest
merscov
protein
undergo
stepwis
cleavag
gener
howev
studi
need
identifi
exact
cleavag
site
determin
whether
cleavag
cell
depend
tissu
specif
shown
previou
report
cov
protein
critic
target
cell
entri
harbor
linear
conform
epitop
neutral
howev
exact
site
precis
entri
step
target
neutral
antibodi
yet
defin
especi
merscov
rbd
merscov
key
function
domain
protein
respons
viru
bind
receptor
target
cell
may
contain
neutral
epitop
found
rrbd
cover
residu
elicit
robust
neutral
antibodi
merscov
immun
mice
block
viral
entri
bind
step
data
consist
recent
report
confirm
rbd
merscov
ideal
immunogen
vaccin
develop
also
found
antiserum
cell
fix
permeabil
stain
either
protein
use
indic
antibodi
chromatin
use
dapi
stain
first
row
repres
protein
second
row
repres
chromatin
cell
analyz
confoc
microscopi
use
object
repres
imag
shown
neutral
assay
screen
rabbit
antisera
rais
peptid
immun
merspp
premix
indic
dilut
sera
inocul
cell
infect
efficaci
monitor
h
postinfect
protocol
normal
neutral
calcul
describ
materi
method
experi
carri
triplic
data
one
repres
case
shown
error
bar
indic
se
mean
yang
et
al
induc
peptid
target
residu
locat
bind
interfac
rbd
accord
recent
crystal
data
elicit
potent
neutral
antibodi
immun
rabbit
howev
high
titer
bind
antibodi
rbd
observ
suggest
lack
neutral
activ
antiserum
could
due
linear
conform
immunogen
data
also
suggest
conform
rbd
essenti
induct
neutral
activ
nonneutr
immunodomin
epitop
exist
rbd
merscov
protein
first
linear
neutral
epitop
locat
outsid
rbd
protein
merscov
report
novel
epitop
target
residu
locat
possibl
proteocleavag
site
merscov
protein
demonstr
neutral
activ
induc
peptid
specif
postbind
membran
fusion
step
mer
infect
data
consist
previou
report
sarscov
indic
human
monoclon
antibodi
direct
proteolyt
cleavag
site
amino
acid
neutral
viru
rhesu
macaqu
sar
model
sinc
multipl
neutral
epitop
identifi
protein
sarscov
envelop
unusu
find
one
neutral
epitop
merscov
protein
summari
panel
peptid
base
bioinformat
predict
confirm
immunogen
studi
rbd
protein
merscov
could
effici
elicit
neutral
antibodi
target
viral
bind
furthermor
found
novel
linear
epitop
target
aminoacid
residu
protein
elicit
robust
neutral
block
viral
entri
postbind
membran
fusion
step
conclud
aminoacid
residu
protein
carri
neutral
epitop
may
use
develop
vaccin
antivir
agent
merscov
fig
specif
neutral
activ
antisera
use
studi
merspp
sarspp
premix
indic
dilut
antisera
inocul
cell
infect
efficaci
monitor
h
postinfect
protocol
normal
neutral
calcul
describ
materi
method
experi
carri
triplic
data
one
repres
case
shown
error
bar
indic
se
mean
fig
inhibit
merspp
infect
antirbd
neutral
antibodi
differ
step
experi
perform
describ
materi
method
briefli
antisera
ad
bind
merspp
cell
protocol
antisera
ad
merspp
bind
target
cell
protocol
ii
mean
valu
se
repres
experi
perform
triplic
shown
statist
signific
differ
p
ttest
neutral
protocol
ii
indic
